AZ’s Farxiga Gets FDA Priority Review For Heart Failure

Moves Ahead of Rival SGLT2 Inhibitors

 
• By Kevin Grogan
  
Priority_Fast_Lane
FDA not keeping AstraZeneca waiting • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cardiovascular

More from Therapeutic Category